William G. Walter - Chairman of the Board, President and Chief Executive Officer
Analyst · Greenwich Consultants
Thanks, Brennen. Good morning everyone. As you saw in our earnings release, we had a record first quarter, a great start to what we expect will be another record year for the company. Summarizing our results, sales of $750 million increased 11% versus the first quarter of 2007. Earnings before restructuring and other income and charges were $1.19 per diluted share, an increase of 29% versus the first quarter of 2007. We achieved double-digit sales and earnings increases in all of our operating segments. Specifically, in Ag Products sales of $278 million increased 12% and earnings of $82.9 million increased 17% versus a year ago, driven by higher sales in Latin America, Asia and Europe, and continued supply chain productivity improvements. In Specialty Chemicals, sales of $184 million and earnings of $39.5 million both increased 11% versus the year-ago quarter. Higher selling prices and volume growth in BioPolymer and lithium specialties drove the performance gains. And in Industrial Chemicals, sales of $290 million increased 11% and earnings of $35.6 million more than doubled versus the year-ago quarter, driven primarily by higher selling prices and volumes across the segment, as well as improved power market conditions in Spain. Our strong first quarter results were achieved despite the combined effect of higher raw material and energy costs across the businesses. Versus the prior year, raw material and energy costs unfavorably impacted earnings by $0.13 per share in the first quarter. Raw materials were the primary driver, as energy costs had a very modest impact relative to a year ago. Currency translation favorably impacted earnings by $0.02 in the quarter. On a GAAP basis then, we reported income of $93.9 million or $1.23 per diluted share. Our GAAP earnings in the current quarter included a net gain of $0.04 per share versus net charges of $0.33 in the prior-year quarter. With that reconciliation, our non-GAAP earrings were $1.19 per diluted share in the current quarter, an increase of 29% versus the $0.92 we earned in the first quarter of 2007. Let me now take a more detailed look at the performance of each of our businesses in the quarter. Moving first to Ag Products. Sales of $278 million increased, as I said, 12% as gains were realized in Latin America, Asia, and Europe. In Latin America, sales growth was particularly strong in Brazil, as we continued to benefit from the country's robust agricultural economy. We experienced demand growth across our entire product portfolio and all crop segments, but particularly in sugar cane, cotton, and soybeans. In Asia, the sales increase was also broad based. Performance gains were achieved in many countries, but were particularly strong in the rice market in India and the winter cereal market in Australia. In Europe, our growth was driven by favorable early season weather conditions and some new product introductions. Ag Products’ earnings of $82.9 million were 17% higher than the record year-ago quarter, reflecting the broad-based sales gains and continued supply chain productivity improvements, which more than offset higher raw material costs, particularly chemical intermediates and solvents. Moving on to Specialty Chemicals, revenue of $184 million and earnings of $39.5 million both increased 11% versus the prior-year quarter, driven by higher selling prices and volume growth in BioPolymer and in lithium specialties. Continued manufacturing productivity improvements were largely offset by higher raw material costs. In BioPolymer, the combination of strong commercial performance in both the pharmaceutical and food ingredients businesses and continued productivity improvements more than offset higher specialty wood pulp, seaweed, and fuel costs. In pharmaceuticals, we benefited from continued growth in demand for oral tablet drugs. Sales in Europe and Asia, and generic drug manufacturers across all regions strong were in the quarter. In food ingredients, our performance was driven by higher selling prices and continued volume growth in Asia and Latin America, primarily in the dairy segment. And in lithium, earnings growth was the result of higher prices and volume growth for specialty lithium compounds, particularly into the pharmaceutical market. Moving on to Industrial Chemicals, revenue of $290 million increased 11% versus the prior-year quarter, driven by higher selling prices and volumes across the segment. Segment earnings of 35.6% more than doubled versus a year ago, as a result of the higher sales and improved power market conditions in Spain. The gains more than offset the higher raw material costs experienced in the segment. In soda ash, market conditions remained tight, as all US soda ash producers continue to operate at full capacity. Both our domestic and export soda ash businesses benefited from new contract terms put in place at the beginning of the year, as higher selling prices were the primary driver of earnings growth. Our North American peroxygens business also performed well in the quarter, realizing higher selling prices and volume growth across both hydrogen peroxide and our specialty peroxygens business. And then Foret achieved significantly improved performance relative to a year ago. Higher prices particularly in phosphates, hydrogen peroxide demand growth, and improved power market conditions were the primary drivers of earnings increase, which more than offset the higher raw material costs, particularly phosphate rock. Moving on to the corporate items. Corporate expense was $11.9 million as compared to $13.1 million a year ago. Interest expense, net, was $8.7 million versus $8.4 million in the prior-year quarter. On March 31, 2008, gross consolidated debt was $615 million and debt, net of cash, was $545 million. For the quarter, depreciation and amortization was $31 million and capital expenditures were $32.6 million. That's the review of the segments. I'd now turn the call over to Kim Foster to report on our financial position. [Audio Gap].